Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
PRISMA HEALTH-MIDLANDS
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
http://prisma-i.it
Clinical Trials
Related News
Comparison of Recurrence of Atrial Fibrillation Post Cryoballon Ablation During the 90-day Blanking Period-with and Without Anti-arrhythmic Drug Therapy
Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Other: No AAD post Ablation.
Subscribe
First Posted Date
2016-09-23
Last Posted Date
2024-10-31
Lead Sponsor
Prisma Health-Midlands
Target Recruit Count
50
Registration Number
NCT02913014
Locations
🇺🇸
Palmetto Health, Columbia, South Carolina, United States
Subscribe
Prev
1
2
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy